1523 related articles for article (PubMed ID: 11114250)
21. Upregulation of the immediate early gene product RhoB by exoenzyme C3 from Clostridium limosum and toxin B from Clostridium difficile.
Huelsenbeck J; Dreger SC; Gerhard R; Fritz G; Just I; Genth H
Biochemistry; 2007 Apr; 46(16):4923-31. PubMed ID: 17397186
[TBL] [Abstract][Full Text] [Related]
22. Rho GTPase Recognition by C3 Exoenzyme Based on C3-RhoA Complex Structure.
Toda A; Tsurumura T; Yoshida T; Tsumori Y; Tsuge H
J Biol Chem; 2015 Aug; 290(32):19423-32. PubMed ID: 26067270
[TBL] [Abstract][Full Text] [Related]
23. Structural constraints-based evaluation of immunogenic avirulent toxins from Clostridium botulinum C2 and C3 toxins as subunit vaccines.
Prisilla A; Prathiviraj R; Sasikala R; Chellapandi P
Infect Genet Evol; 2016 Oct; 44():17-27. PubMed ID: 27320793
[TBL] [Abstract][Full Text] [Related]
24. Substrate N
Yoshida T; Tsuge H
J Biol Chem; 2018 Sep; 293(36):13768-13774. PubMed ID: 30072382
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide.
Bell CE; Eisenberg D
Biochemistry; 1996 Jan; 35(4):1137-49. PubMed ID: 8573568
[TBL] [Abstract][Full Text] [Related]
26. Bacterial toxins and the Rho GTP-binding protein: what microbes teach us about cell regulation.
Fiorentini C; Gauthier M; Donelli G; Boquet P
Cell Death Differ; 1998 Sep; 5(9):720-8. PubMed ID: 10200530
[TBL] [Abstract][Full Text] [Related]
27. Structure of the Rho-activating domain of Escherichia coli cytotoxic necrotizing factor 1.
Buetow L; Flatau G; Chiu K; Boquet P; Ghosh P
Nat Struct Biol; 2001 Jul; 8(7):584-8. PubMed ID: 11427886
[TBL] [Abstract][Full Text] [Related]
28. Studies on the active-site structure of C3-like exoenzymes: involvement of glutamic acid in catalysis of ADP-ribosylation.
Aktories K; Jung M; Böhmer J; Fritz G; Vandekerckhove J; Just I
Biochimie; 1995; 77(5):326-32. PubMed ID: 8527485
[TBL] [Abstract][Full Text] [Related]
29. Purification and activity of the Rho ADP-ribosylating binary C2/C3 toxin.
Haug G; Barth H; Aktories K
Methods Enzymol; 2006; 406():117-27. PubMed ID: 16472654
[TBL] [Abstract][Full Text] [Related]
30. Structure and action of the binary C2 toxin from Clostridium botulinum.
Schleberger C; Hochmann H; Barth H; Aktories K; Schulz GE
J Mol Biol; 2006 Dec; 364(4):705-15. PubMed ID: 17027031
[TBL] [Abstract][Full Text] [Related]
31. The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile.
Just I; Selzer J; von Eichel-Streiber C; Aktories K
J Clin Invest; 1995 Mar; 95(3):1026-31. PubMed ID: 7883950
[TBL] [Abstract][Full Text] [Related]
32. Distinct biological activities of C3 and ADP-ribosyltransferase-deficient C3-E174Q.
Rohrbeck A; Kolbe T; Hagemann S; Genth H; Just I
FEBS J; 2012 Aug; 279(15):2657-71. PubMed ID: 22621765
[TBL] [Abstract][Full Text] [Related]
33. ADP-ribosylation of Rho-proteins with botulinum C3 exoenzyme inhibits invasion and shape changes of T-lymphoma cells.
Verschueren H; De Baetselier P; De Braekeleer J; Dewit J; Aktories K; Just I
Eur J Cell Biol; 1997 Jun; 73(2):182-7. PubMed ID: 9208232
[TBL] [Abstract][Full Text] [Related]
34. ADP-ribosylation of rho by C3 ribosyltransferase inhibits IL-2 production and sustained calcium influx in activated T cells.
Angkachatchai V; Finkel TH
J Immunol; 1999 Oct; 163(7):3819-25. PubMed ID: 10490980
[TBL] [Abstract][Full Text] [Related]
35. Role of guanine nucleotide-binding proteins in Clostridium botulinum pathology: purification of substrates for Clostridium botulinum C3 ADP-ribosyltransferase with different requirements for GTP and phospholipids.
Williamson KC; Smith LA; Moss J; Vaughan M
Trans Assoc Am Physicians; 1990; 103():281-8. PubMed ID: 2132538
[No Abstract] [Full Text] [Related]
36. Crystal structure and site-directed mutagenesis of enzymatic components from Clostridium perfringens iota-toxin.
Tsuge H; Nagahama M; Nishimura H; Hisatsune J; Sakaguchi Y; Itogawa Y; Katunuma N; Sakurai J
J Mol Biol; 2003 Jan; 325(3):471-83. PubMed ID: 12498797
[TBL] [Abstract][Full Text] [Related]
37. Active site mutation of the C3-like ADP-ribosyltransferase from Clostridium limosum--analysis of glutamic acid 174.
Böhmer J; Jung M; Sehr P; Fritz G; Popoff M; Just I; Aktories K
Biochemistry; 1996 Jan; 35(1):282-9. PubMed ID: 8555186
[TBL] [Abstract][Full Text] [Related]
38. C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins.
Vogelsgesang M; Pautsch A; Aktories K
Naunyn Schmiedebergs Arch Pharmacol; 2007 Feb; 374(5-6):347-60. PubMed ID: 17146673
[TBL] [Abstract][Full Text] [Related]
39. Crystal structure of nicotinic acid mononucleotide adenylyltransferase from Staphyloccocus aureus: structural basis for NaAD interaction in functional dimer.
Han S; Forman MD; Loulakis P; Rosner MH; Xie Z; Wang H; Danley DE; Yuan W; Schafer J; Xu Z
J Mol Biol; 2006 Jul; 360(4):814-25. PubMed ID: 16784754
[TBL] [Abstract][Full Text] [Related]
40. Clostridial ADP-ribosylating toxins: effects on ATP and GTP-binding proteins.
Aktories K
Mol Cell Biochem; 1994 Sep; 138(1-2):167-76. PubMed ID: 7898461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
